Enanta Pharma (ENTA) Tops Q4 EPS by 5c

November 21, 2016 4:06 PM EST
Get Alerts ENTA Hot Sheet
Trade ENTA Now!
Join SI Premium – FREE

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Enanta Pharma (NASDAQ: ENTA) reported Q4 EPS of ($0.09), $0.05 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $12.8 million versus the consensus estimate of $13.23 million.

For earnings history and earnings-related data on Enanta Pharma (ENTA) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment